1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsPancreatic Cancer Research is sponsored by Lustgarten Foundation. The Lustgarten Foundation is the largest private funder of pancreatic cancer research globally, investing in high-risk, high-reward research to accelerate and expand life-saving treatment options.
Get alerted about grants like this
Get emailed when new opportunities from “Lustgarten Foundation” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Lustgarten Foundation Innovation and Collaboration Program The Lustgarten Foundation Innovation and Collaboration Program intends to provide seed funding for highly innovative research with significant potential to accelerate the mission of the Lustgarten Foundation. Proposals should address key outstanding questions and have the potential to lead to a change in the current paradigm or conventional wisdom.
Proposals that involve collaborations across groups or that bring new expertise and/or technology into the field will be preferred. Applications are due January 5, 2026 Must be submitted through ProposalCentral See the complete RFA details for more information. Lustgarten Foundation point of contact: Sejin Chung, Program Scientist ( [email protected] ) Robert F.
Vizza Clinical Accelerator Initiative The Clinical Accelerator Initiative (CAI) advances the mission of the Lustgarten Foundation by accelerating the translation of research discoveries into the clinic. CAI studies are highly collaborative, science-driven and typically small in order to support deep translational analyses and as many learnings as possible.
Letter of Intent (LOI) submissions are due November 2, 2026 Submissions must be through ProposalCentral Invitations Extended for TAG Presentations: by January 2027 Invitations Extended for Grant Applications: by March 2027 Award Notifications: by July 2027 Lustgarten Equity, Accessibility, and Diversity (LEAD) Project Pancreatic cancer does not impact all populations equally with significant differences in incidence and disparities in outcome across racial, ethnic, and socioeconomic groups in the United States.
Despite this, pancreatic cancer patients from minority groups are significantly underrepresented in all phases of clinical trials.
The LEAD Project aims to increase recruitment and retention of underrepresented groups in pancreatic cancer clinical trials by supporting institutions that make intentional efforts to address barriers to participation among underrepresented groups and develop and implement specific tools to increase clinical trial participation.
Applications are due January 5, 2026 Must be submitted through ProposalCentral See the complete RFA details for more information.
Lustgarten Foundation point of contact: Sejin Chung, Program Scientist ( [email protected] ) Lustgarten Foundation-AACR Career Development Awards for Pancreatic Cancer Research, in Honor of Ruth Bader Ginsburg and John Robert Lewis The Lustgarten Foundation-AACR Career Development Awards for Pancreatic Cancer Research, in Honor of Ruth Bader Ginsburg and John Robert Lewis, have been established to honor the life and legacies of Justice Ginsburg and Representative Lewis, who worked tirelessly to advance gender equality and civil rights, even while battling pancreatic cancer.
The intent of this program is to support the development and diversity of talent working in pancreatic cancer research. A full description of the programs are available at www. aacr.
org/grants/ . Lustgarten Research Program Contacts: Head of Clinical Research and Development Tell us a little more about yourself:
According to the current listing, eligibility includes: Pancreatic cancer researchers and institutions. Specific calls for applications would be detailed on their official website. Confirm the full requirements in the official notice before applying.
The current listing shows not specified (invested over $333M to date). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Pancreatic Cancer Research is funded by Lustgarten Foundation. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward interdisciplinary projects that leverage AI, machine learning, and advanced data science to address pressing questions in biomedical and public health research. It seeks to advance fundamental scientific and engineering contributions across disciplines to solve key health problems.